Connected profiles10
Exact peptide identities attached to retained registry observations carrying this condition label.
Coverage-gated living condition brief
Type 2 Diabetes peptide evidence brief
A cited Type 2 Diabetes peptide evidence brief across 13 exact-label ClinicalTrials.gov records, 10 connected profiles, and 6 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
Registry records
13 selected records.
Connected peptides
10 profiles.
Registry update years
2014–2026 in selected records.
Direct collection answer · published August 17, 2026
What peptide evidence does PeptideScanner carry for Type 2 Diabetes?
PeptideScanner’s selected collection contains 13 retained ClinicalTrials.gov records carrying the exact condition label “Type 2 Diabetes,” connected to 10 peptide profiles across 6 registry-update years.
That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats Type 2 Diabetes, and it is not a safety or efficacy assessment.
Indication intelligence
Selected evidence landscape
Trial phases4
Phase labels copied from the retained ClinicalTrials.gov versions.
Phase 3 (6)Phase 4 (3)Phase 2 (1)Not applicable (1)
Registry statuses4
Overall statuses at each retained observation, not necessarily current today.
Completed (9)Recruiting (2)Not yet recruiting (1)Active, not recruiting (1)
Across the connected peptide profiles, PeptideScanner also carries 303 selected PubMed records and 25 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Type 2 Diabetes unless their own cited source says so.
Related profile context
Literature connected through these peptide profiles
This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern Type 2 Diabetes.
Dulaglutide · source record 2026-01-27
Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus.
PubMed lists PMID 29094890 in American family physician as Journal Article, with publication-date metadata of 2017-10-15 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Exenatide · source record 2026-09-08
Development of Chondroitin Sulfate ‑ Stabilized PLGA Microspheres of Exenatide via Polarity Gradient Extraction.
PubMed lists PMID 42709517 in Pharmaceutical development and technology as Journal Article, with publication-date metadata of 2026-09-08 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Liraglutide · source record 2026-09-08
Monitoring Liraglutide Oligomeric Interconversion and Fibril Dissociation through High-Pressure NMR Spectroscopy.
PubMed lists PMID 42708757 in Analytical chemistry as Journal Article, with publication-date metadata of 2026-09-08 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Lixisenatide · source record 2026-01-27
Insulin degludec, Lixisenatide, and Patiromer sorbitex calcium.
PubMed lists PMID 27836130 in Journal of the American Pharmacists Association : JAPhA as Journal Article, with publication-date metadata of 2016 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Retatrutide · source record 2025-09-02
Retatrutide.
PubMed lists PMID 39429457 in Clinical diabetes : a publication of the American Diabetes Association as Journal Article, with publication-date metadata of 2024-08-01 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Semaglutide · source record 2026-09-09
"I Believe in Santa Claus" and Ozempic: A Foucauldian Discourse Analysis of Holiday Health Advertising.
PubMed lists PMID 40536021 in Qualitative health research as Journal Article, with publication-date metadata of 2025-06-19 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
Record added
ClinicalTrials.gov record NCT01364584
PeptideScanner retained ClinicalTrials.gov record NCT01364584 at 2026-07-30T19:10:42.711Z. Its registry update date was 2023-07-12, and PeptideScanner's reviewed identity mapping was exenatide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- July 12, 2023
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT06926842
PeptideScanner retained ClinicalTrials.gov record NCT06926842 at 2026-09-09T19:17:17.080Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was petrelintide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- September 9, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT07083154
PeptideScanner retained ClinicalTrials.gov record NCT07083154 at 2026-09-09T19:17:17.091Z. Its registry update date was 2026-09-02, and PeptideScanner's reviewed identity mapping was mazdutide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- September 2, 2026
- Evidence lane
- Clinical trials
Exact-record source chronology
Type 2 Diabetes registry timeline
Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.
2026
7 recordsPetrelintide · 2026-09-09
ClinicalTrials.gov record NCT06926842
Completed at the retained observation.
Open cited registry record →Mazdutide · 2026-09-02
ClinicalTrials.gov record NCT07083154
Recruiting at the retained observation.
Open cited registry record →Survodutide · 2026-08-10
ClinicalTrials.gov record NCT07754461
Not yet recruiting at the retained observation.
Open cited registry record →Dulaglutide · 2026-08-07
ClinicalTrials.gov record NCT06739122
Recruiting at the retained observation.
Open cited registry record →Cagrilintide · 2026-08-03
ClinicalTrials.gov record NCT07220759
Active, not recruiting at the retained observation.
Open cited registry record →Retatrutide · 2026-07-30
ClinicalTrials.gov record NCT05929079
Completed at the retained observation.
Open cited registry record →Dulaglutide · 2026-07-10
ClinicalTrials.gov record NCT07417631
Completed at the retained observation.
Open cited registry record →2024
1 recordLixisenatide · 2024-12-16
ClinicalTrials.gov record NCT02049034
Completed at the retained observation.
Open cited registry record →2023
2 recordsExenatide · 2023-12-29
ClinicalTrials.gov record NCT01524705
Completed at the retained observation.
Open cited registry record →Exenatide · 2023-07-12
ClinicalTrials.gov record NCT01364584
Completed at the retained observation.
Open cited registry record →2020
1 recordSemaglutide · 2020-02-21
ClinicalTrials.gov record NCT04175665
Completed at the retained observation.
Open cited registry record →2015
1 recordLiraglutide · 2015-03-25
ClinicalTrials.gov record NCT01755572
Completed at the retained observation.
Open cited registry record →2014
1 recordLiraglutide · 2014-09-12
ClinicalTrials.gov record NCT01270789
Completed at the retained observation.
Open cited registry record →- Condition matching is limited to exact labels on retained ClinicalTrials.gov v3 observations; PeptideScanner does not merge related diagnoses or synonyms.
- Coverage is selective and historical, not a complete or continuously current account of the registry or PubMed.
- The brief does not synthesize study outcomes, compare interventions, or make safety, efficacy, diagnosis, or treatment claims.